OFIX News and Press, Orthofix Medical Inc. From 08/05/25

Orthofix Medical Inc. (OFIX) is expected to report $-0.44 for Q2 2025

2025-07-22 03:40:00 ET Our RAM Smid composite gained 6.11% in 2Q25, slightly trailing the Russell 2500 Value Total Return index which rose 7.29%. Given the strategy’s concentrated nature, with 28 positions at quarter end, some performance variability relative to the benchmark is ...

Wednesday, August 13, 2025 at 9:00 am Eastern Time Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canaccord Genuity 45th Annual Growth Conference in Boston. Management is scheduled to pr...

Company to Host Conference Call on Tuesday, August 5, 2025 at 8:30 am Eastern Time Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 before ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the global commercial launch of the TrueLok™ Elevate Transverse Bone Transport (TBT) System. TrueLok Elevate represents the first commercially available device in the U.S. with a patented desi...

2025-05-06 14:39:33 ET More on Orthofix Medical Inc. Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Call Transcript Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript Orthofix Medical Inc. 2024 Q4 - Results - Earnings Call Presentation Orthofix Medi...

2025-05-06 14:39:02 ET Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Conference Call May 06, 2025 08:30 AM ET Company Participants Julie Dewey - Chief Investor Relations and Communications Officer Massimo Calafiore - President and Chief Executive Officer Julie An...

2025-05-06 07:06:52 ET More on Orthofix Medical Inc. Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript Orthofix Medical Inc. 2024 Q4 - Results - Earnings Call Presentation Orthofix gets FDA clearance and CE Mark for its limb preservation solution ...

Cyclerion Therapeutics Inc. (CYCN) is expected to report for Q1 2025 Standard BioTools Inc. (LAB) is expected to report $-0.06 for Q1 2025 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2025 CF Bankshares Inc. (CFBK) is expected to report for Q1 2025 Jack Henry & A...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow ...